• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病风险预测模型及中国老年人群健康管理策略:一项横断面研究。

Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.

机构信息

Department of Health Management, School of Public Health, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Shanghai Collaborative Innovation Centre of Health Service in Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

出版信息

Lipids Health Dis. 2023 Nov 25;22(1):205. doi: 10.1186/s12944-023-01966-1.

DOI:10.1186/s12944-023-01966-1
PMID:38007441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10675849/
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver condition that affects a quarter of the global adult population. To date, only a few NAFLD risk prediction models have been developed for Chinese older adults aged ≥ 60 years. This study presented the development of a risk prediction model for NAFLD in Chinese individuals aged ≥ 60 years and proposed personalised health interventions based on key risk factors to reduce NAFLD incidence among the population.

METHODS

A cross-sectional survey was carried out among 9,041 community residents in Shanghai. Three NAFLD risk prediction models (I, II, and III) were constructed using multivariate logistic regression analysis based on the least absolute shrinkage and selection operator regression analysis, and random forest model to select individual characteristics, respectively. To determine the optimal model, the three models' discrimination, calibration, clinical application, and prediction capability were evaluated using the receiver operating characteristic (ROC) curve, calibration plot, decision curve analysis, and net reclassification index (NRI), respectively. To evaluate the optimal model's effectiveness, the previously published NAFLD risk prediction models (Hepatic steatosis index [HSI] and ZJU index) were evaluated using the following five indicators: accuracy, precision, recall, F1-score, and balanced accuracy. A dynamic nomogram was constructed for the optimal model, and a Bayesian network model for predicting NAFLD risk in older adults was visually displayed using Netica software.

RESULTS

The area under the ROC curve of Models I, II, and III in the training dataset was 0.810, 0.826, and 0.825, respectively, and that of the testing data was 0.777, 0.797, and 0.790, respectively. No significant difference was found in the accuracy or NRI between the models; therefore, Model III with the fewest variables was determined as the optimal model. Compared with the HSI and ZJU index, Model III had the highest accuracy (0.716), precision (0.808), recall (0.605), F1 score (0.692), and balanced accuracy (0.723). The risk threshold for Model III was 20%-80%. Model III included body mass index, alanine aminotransferase level, triglyceride level, and lymphocyte count.

CONCLUSIONS

A dynamic nomogram and Bayesian network model were developed to identify NAFLD risk in older Chinese adults, providing personalized health management strategies and reducing NAFLD incidence.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是一种常见的慢性肝脏疾病,影响全球四分之一的成年人口。迄今为止,只有少数 NAFLD 风险预测模型针对年龄≥60 岁的中国老年人开发。本研究旨在为年龄≥60 岁的中国个体建立一个 NAFLD 风险预测模型,并基于关键风险因素提出个性化健康干预措施,以降低人群中 NAFLD 的发病率。

方法

在上海的 9041 名社区居民中进行了一项横断面调查。使用多元逻辑回归分析基于最小绝对收缩和选择算子回归分析以及随机森林模型分别选择个体特征,构建了三个 NAFLD 风险预测模型(I、II 和 III)。为了确定最佳模型,使用接收者操作特征(ROC)曲线、校准图、决策曲线分析和净重新分类指数(NRI)分别评估了三个模型的区分度、校准度、临床应用和预测能力。为了评估最佳模型的效果,使用以下五个指标评估了先前发表的 NAFLD 风险预测模型(肝脂肪变性指数[HSI]和 ZJU 指数):准确性、精密度、召回率、F1 分数和平衡准确性。为最佳模型构建了一个动态列线图,并使用 Netica 软件通过贝叶斯网络模型直观地显示了预测老年人 NAFLD 风险的模型。

结果

在训练数据集中,模型 I、II 和 III 的 ROC 曲线下面积分别为 0.810、0.826 和 0.825,在测试数据集中分别为 0.777、0.797 和 0.790。模型之间在准确性或 NRI 方面没有发现显著差异,因此确定具有最少变量的模型 III 为最佳模型。与 HSI 和 ZJU 指数相比,模型 III 具有最高的准确性(0.716)、精密度(0.808)、召回率(0.605)、F1 分数(0.692)和平衡准确性(0.723)。模型 III 的风险阈值为 20%-80%。模型 III 包含体重指数、丙氨酸氨基转移酶水平、甘油三酯水平和淋巴细胞计数。

结论

开发了一个动态列线图和贝叶斯网络模型来识别中国老年人群中 NAFLD 的风险,提供个性化的健康管理策略并降低 NAFLD 的发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/77ef2e22625e/12944_2023_1966_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/7548722c78dd/12944_2023_1966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/ac044a6f00b1/12944_2023_1966_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/e4babc7459a2/12944_2023_1966_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/5470d00d5ce8/12944_2023_1966_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/d571b79a7a38/12944_2023_1966_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/77ef2e22625e/12944_2023_1966_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/7548722c78dd/12944_2023_1966_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/ac044a6f00b1/12944_2023_1966_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/e4babc7459a2/12944_2023_1966_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/5470d00d5ce8/12944_2023_1966_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/d571b79a7a38/12944_2023_1966_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0027/10675849/77ef2e22625e/12944_2023_1966_Fig6_HTML.jpg

相似文献

1
Non-alcoholic fatty liver disease risk prediction model and health management strategies for older Chinese adults: a cross-sectional study.非酒精性脂肪性肝病风险预测模型及中国老年人群健康管理策略:一项横断面研究。
Lipids Health Dis. 2023 Nov 25;22(1):205. doi: 10.1186/s12944-023-01966-1.
2
Development and validation of a clinical and laboratory-based nomogram to predict nonalcoholic fatty liver disease.开发和验证一种基于临床和实验室的列线图,以预测非酒精性脂肪性肝病。
Hepatol Int. 2020 Sep;14(5):808-816. doi: 10.1007/s12072-020-10065-7. Epub 2020 Jun 22.
3
A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study.基于临床和实验室的非糖尿病成人非酒精性脂肪肝预测列线图:一项横断面研究。
Ann Palliat Med. 2022 Jul;11(7):2349-2359. doi: 10.21037/apm-21-2988. Epub 2022 May 10.
4
Nomogram for predicting the risk of nonalcoholic fatty liver disease in older adults in Qingdao, China: A cross-sectional study.中国青岛老年人非酒精性脂肪性肝病风险预测列线图:一项横断面研究。
Asia Pac J Clin Nutr. 2024 Mar;33(1):83-93. doi: 10.6133/apjcn.202403_33(1).0009.
5
A nomogram incorporated lifestyle indicators for predicting nonalcoholic fatty liver disease.纳入生活方式指标的列线图预测非酒精性脂肪性肝病。
Medicine (Baltimore). 2021 Jul 2;100(26):e26415. doi: 10.1097/MD.0000000000026415.
6
Risk Prediction for Non-alcoholic Fatty Liver Disease Based on Biochemical and Dietary Variables in a Chinese Han Population.基于中国汉族人群生化和饮食变量的非酒精性脂肪肝疾病风险预测。
Front Public Health. 2020 Jul 2;8:220. doi: 10.3389/fpubh.2020.00220. eCollection 2020.
7
Development and application of a novel model to predict the risk of non-alcoholic fatty liver disease among lean pre-diabetics with normal blood lipid levels.开发和应用一种新模型预测血脂正常的消瘦型糖尿病前期人群中非酒精性脂肪肝疾病的风险。
Lipids Health Dis. 2022 Dec 31;21(1):149. doi: 10.1186/s12944-022-01752-5.
8
A Prediction Model Based on Noninvasive Indicators to Predict the 8-Year Incidence of Type 2 Diabetes in Patients with Nonalcoholic Fatty Liver Disease: A Population-Based Retrospective Cohort Study.基于非侵入性指标预测非酒精性脂肪性肝病患者 8 年内 2 型糖尿病发病风险的预测模型:一项基于人群的回顾性队列研究。
Biomed Res Int. 2021 May 14;2021:5527460. doi: 10.1155/2021/5527460. eCollection 2021.
9
Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.利用机器学习模型预测非酒精性脂肪性肝病的 5 年风险:前瞻性队列研究。
J Med Internet Res. 2023 Sep 12;25:e46891. doi: 10.2196/46891.
10
A Nomogram Model Based on Noninvasive Bioindicators to Predict 3-Year Risk of Nonalcoholic Fatty Liver in Nonobese Mainland Chinese: A Prospective Cohort Study.基于无创生物标志物的列线图模型预测非肥胖中国大陆人群 3 年非酒精性脂肪肝风险:一项前瞻性队列研究。
Biomed Res Int. 2020 Nov 2;2020:8852198. doi: 10.1155/2020/8852198. eCollection 2020.

引用本文的文献

1
Relationship Between the ZJU Index and Infertility Risk in Reproductive-Aged US Women: An Analysis of NHANES 2013-2018.美国育龄女性中浙江大学指数与不孕风险的关系:对2013 - 2018年美国国家健康与营养检查调查(NHANES)的分析
Int J Womens Health. 2025 Jul 14;17:2063-2073. doi: 10.2147/IJWH.S527967. eCollection 2025.
2
Inappropriate Diet Exacerbates Metabolic Dysfunction-Associated Steatotic Liver Disease via Abdominal Obesity.不当饮食通过腹部肥胖加剧代谢功能障碍相关脂肪性肝病。
Nutrients. 2024 Dec 5;16(23):4208. doi: 10.3390/nu16234208.
3
Association between life's essential 8 and metabolic dysfunction-associated steatotic liver disease among US adults.

本文引用的文献

1
Development and validation of a nomogram for predicting metabolic-associated fatty liver disease in the Chinese physical examination population.开发和验证适用于中国体检人群的预测代谢相关脂肪性肝病的列线图。
Lipids Health Dis. 2023 Jun 29;22(1):85. doi: 10.1186/s12944-023-01850-y.
2
The link between lymphocyte subpopulations in peripheral blood and metabolic variables in patients with severe obesity.外周血淋巴细胞亚群与重度肥胖患者代谢变量之间的关系。
PeerJ. 2023 Jun 13;11:e15465. doi: 10.7717/peerj.15465. eCollection 2023.
3
Age-Related NAFLD: The Use of Probiotics as a Supportive Therapeutic Intervention.
美国成年人中生命必需的八项指标与代谢功能障碍相关脂肪性肝病之间的关联。
Arch Public Health. 2024 Jul 5;82(1):101. doi: 10.1186/s13690-024-01331-3.
4
Nomogram for predicting 5-year metabolic dysfunction-associated steatotic liver disease risk: retrospective cohort study.预测5年代谢功能障碍相关脂肪性肝病风险的列线图:回顾性队列研究
Endocr Connect. 2024 Jul 13;13(8). doi: 10.1530/EC-24-0186. Print 2024 Aug 1.
年龄相关性非酒精性脂肪性肝病:益生菌作为一种支持性治疗干预的应用。
Cells. 2022 Sep 10;11(18):2827. doi: 10.3390/cells11182827.
4
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.全球非酒精性脂肪性肝病的患病率和发病率:系统评价和荟萃分析。
Lancet Gastroenterol Hepatol. 2022 Sep;7(9):851-861. doi: 10.1016/S2468-1253(22)00165-0. Epub 2022 Jul 5.
5
A global view of the interplay between non-alcoholic fatty liver disease and diabetes.非酒精性脂肪性肝病与糖尿病之间相互作用的全球观。
Lancet Diabetes Endocrinol. 2022 Apr;10(4):284-296. doi: 10.1016/S2213-8587(22)00003-1. Epub 2022 Feb 17.
6
The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.肥胖和脂质相关指标对预测非酒精性脂肪性肝病的存在的有用性。
Lipids Health Dis. 2021 Oct 10;20(1):134. doi: 10.1186/s12944-021-01561-2.
7
NAFLD in the Elderly.老年人非酒精性脂肪性肝病。
Clin Interv Aging. 2021 Sep 13;16:1633-1649. doi: 10.2147/CIA.S295524. eCollection 2021.
8
Kruppel-like factor 15 induces the development of mature hepatocyte-like cells from hepatoblasts.Kruppel 样因子 15 诱导肝母细胞向成熟肝细胞样细胞的发育。
Sci Rep. 2021 Sep 17;11(1):18551. doi: 10.1038/s41598-021-97937-6.
9
Comparison and development of advanced machine learning tools to predict nonalcoholic fatty liver disease: An extended study.比较和开发先进的机器学习工具预测非酒精性脂肪性肝病:一项扩展研究。
Hepatobiliary Pancreat Dis Int. 2021 Oct;20(5):409-415. doi: 10.1016/j.hbpd.2021.08.004. Epub 2021 Aug 14.
10
Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD?研究结果表明肥胖具有病毒性起源,但与肥胖相关的非酒精性脂肪性肝病(NAFLD)呢?
Viruses. 2021 Jul 1;13(7):1285. doi: 10.3390/v13071285.